(Q38877849)

English

MicroRNA-429 suppresses cell proliferation, epithelial-mesenchymal transition, and metastasis by direct targeting of BMI1 and E2F3 in renal cell carcinoma

scientific article published on 4 May 2015

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

MicroRNA-429 suppresses cell proliferation, epithelial-mesenchymal transition, and metastasis by direct targeting of BMI1 and E2F3 in renal cell carcinoma (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

1 reference

based on heuristic

inferred from title

author name string

Mingning Qiu

1

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Ziji Liang

2

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Lieqian Chen

3

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Guobin Tan

4

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Kangning Wang

5

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Lei Liu

6

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Jianjun Liu

7

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Hege Chen

8

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

publication date

4 May 2015

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Urologic Oncology

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

33

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

332.e9-18

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Cancer statistics, 2014

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.03.016

7 January 2021

Cancer treatment and survivorship statistics, 2014

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.03.016

7 January 2021

Epidemiology and risk factors for kidney cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.03.016

7 January 2021

Maturing of renal cancer therapeutics.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.03.016

7 January 2021

The epithelial-mesenchymal transition generates cells with properties of stem cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.03.016

7 January 2021

Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.03.016

7 January 2021

Epithelial-mesenchymal transitions in tumour progression

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.03.016

7 January 2021

Epithelial-mesenchymal transitions: twist in development and metastasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.03.016

7 January 2021

MicroRNAs: genomics, biogenesis, mechanism, and function

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.03.016

7 January 2021

The widespread regulation of microRNA biogenesis, function and decay

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.03.016

7 January 2021

microRNAs: tiny regulators with great potential

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.03.016

7 January 2021

microRNAs as oncogenes and tumor suppressors

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.03.016

7 January 2021

MiR-200, a new star miRNA in human cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.03.016

7 January 2021

The role of the miR-200 family in epithelial-mesenchymal transition

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.03.016

7 January 2021

microRNA-200c modulates the epithelial-to-mesenchymal transition in human renal cell carcinoma metastasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.03.016

7 January 2021

The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.03.016

7 January 2021

The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.03.016

7 January 2021

The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.03.016

7 January 2021

Involvement of E-cadherin, beta-catenin, Cdc42 and CXCR4 in the progression and prognosis of cutaneous melanoma.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.03.016

7 January 2021

Epigenetic factors in cancer development: polycomb group proteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.03.016

7 January 2021

The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.03.016

7 January 2021

The Bmi-1 oncoprotein is overexpressed in human colorectal cancer and correlates with the reduced p16INK4a/p14ARF proteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.03.016

7 January 2021

The INK4a/ARF network in tumour suppression

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.03.016

7 January 2021

Implication of polycomb members Bmi-1, Mel-18, and Hpc-2 in the regulation of p16INK4a, p14ARF, h-TERT, and c-Myc expression in primary breast carcinomas.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.03.016

7 January 2021

Role of E2F3 expression in modulating cellular proliferation rate in human bladder and prostate cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.03.016

7 January 2021

An E2F/miR-20a autoregulatory feedback loop.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.03.016

7 January 2021

MicroRNA-125b suppresses the development of bladder cancer by targeting E2F3.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.03.016

7 January 2021

Nuclear overexpression of the E2F3 transcription factor in human lung cancer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.03.016

7 January 2021

miR-200c inhibits invasion, migration and proliferation of bladder cancer cells through down-regulation of BMI-1 and E2F3

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.03.016

7 January 2021

Causes and consequences of microRNA dysregulation in cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.03.016

7 January 2021

miR-429 inhibits migration and invasion of breast cancer cells in vitro

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.03.016

7 January 2021

MiR-429 inhibits cells growth and invasion and regulates EMT-related marker genes by targeting Onecut2 in colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.03.016

7 January 2021

MiR-429 up-regulation induces apoptosis and suppresses invasion by targeting Bcl-2 and SP-1 in esophageal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.03.016

7 January 2021

Epithelial-mesenchymal transition-related microRNA-200s regulate molecular targets and pathways in renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.03.016

7 January 2021

Differential microRNA expression in renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.03.016

7 January 2021

Tumor suppressive microRNA-1285 regulates novel molecular targets: aberrant expression and functional significance in renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.03.016

7 January 2021

High expression of serum miR-21 and tumor miR-200c associated with poor prognosis in patients with lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.03.016

7 January 2021

p53 regulates epithelial-mesenchymal transition and stem cell properties through modulating miRNAs.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.03.016

7 January 2021

miR-203 inhibits the proliferation and self-renewal of esophageal cancer stem-like cells by suppressing stem renewal factor Bmi-1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.03.016

7 January 2021

Direct effects of Bmi1 on p53 protein stability inactivates oncoprotein stress responses in embryonal cancer precursor cells at tumor initiation.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.03.016

7 January 2021

ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.03.016

7 January 2021

Transcription factor E2F3 overexpressed in prostate cancer independently predicts clinical outcome

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.03.016

7 January 2021

MicroRNA-503 inhibits the G1/S transition by downregulating cyclin D3 and E2F3 in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.03.016

7 January 2021

Contrasting roles of E2F2 and E2F3 in endothelial cell growth and ischemic angiogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.03.016

7 January 2021

Metastasis: new perspectives on an old problem

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.03.016

7 January 2021

Epithelial-mesenchymal transitioned circulating tumor cells capture for detecting tumor progression

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.03.016

7 January 2021

The polycomb group protein Bmi-1 represses the tumor suppressor PTEN and induces epithelial-mesenchymal transition in human nasopharyngeal epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.03.016

7 January 2021

Identifiers

10.1016/J.UROLONC.2015.03.016

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38877849&oldid=1792974160"